Fundación para el Estudio y Tratamiento de Enfermedades Mentales (FETEM)

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Brenipatide in Adult Participants With Schizophrenia	Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia	Recruiting	Phase 2	2026-10-07		NCT07410507
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)	Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Active, not recruiting	Phase 3	2026-09-22		NCT05508789

Clinical trials